Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Insulin resistance appears to be the best predictor of the development of diabetes in the children of patients with type 2 diabetes, but the mechanism responsible is unknown. METHODS: We performed hyperinsulinemic-euglycemic clamp studies in combination with infusions of [6,6-(2)H(2)]glucose in healthy, young, lean, insulin-resistant offspring of patients with type 2 diabetes and insulin-sensitive control subjects matched for age, height, weight, and physical activity to assess the sensitivity of liver and muscle to insulin. Proton ((1)H) magnetic resonance spectroscopy studies were performed to measure intramyocellular lipid and intrahepatic triglyceride content. Rates of whole-body and subcutaneous fat lipolysis were assessed by measuring the rates of [(2)H(5)]glycerol turnover in combination with microdialysis measurements of glycerol release from subcutaneous fat. We performed (31)P magnetic resonance spectroscopy studies to assess the rates of mitochondrial oxidative-phosphorylation activity in muscle. RESULTS: The insulin-stimulated rate of glucose uptake by muscle was approximately 60 percent lower in the insulin-resistant subjects than in the insulin-sensitive control subjects (P<0.001) and was associated with an increase of approximately 80 percent in the intramyocellular lipid content (P=0.005). This increase in intramyocellular lipid content was most likely attributable to mitochondrial dysfunction, as reflected by a reduction of approximately 30 percent in mitochondrial phosphorylation (P=0.01 for the comparison with controls), since there were no significant differences in systemic or localized rates of lipolysis or plasma concentrations of tumor necrosis factor alpha, interleukin-6, resistin, or adiponectin. CONCLUSIONS: These data support the hypothesis that insulin resistance in the skeletal muscle of insulin-resistant offspring of patients with type 2 diabetes is associated with dysregulation of intramyocellular fatty acid metabolism, possibly because of an inherited defect in mitochondrial oxidative phosphorylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Although the existence of mitochondrial abnormalities in patients with type 2 diabetes has been extensively reported during the last decade (1–5), there is no evidence that a reduced mitochondrial function is a primary factor in the pathophysiology of this disease.”
From Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance (2010) · cites this paper as [2]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This hypothesis is based on the finding that type 2 diabetics and insulin-resistant individuals with impaired glucose tolerance have ≈30% less mitochondria in their muscles than insulin-sensitive control subjects (3–7).”
From High-fat diets cause insulin resistance despite an increase in muscle mitochondria (2008) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, lean healthy offspring of diabetic parents have a significant decrease in insulin-stimulated total body and muscle glucose disposal which is of a similar magnitude to that observed in their diabetic parents [30–32].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This hypothesis is supported by in vivo reports that the incorporation of 13 C-acetate into glutamate and mitochondrial phosphorylation was approximately 30% lower in muscle of insulin-resistant versus lean individuals (81,83).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [81]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and that insulin resistance is strongly associated with increases in hepatic (HTG) and ∕ or intramyocellular lipid content”
From Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men (2006) · cites this paper as [11]
Experimental — accuracy not yet measured
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J., Burema, J., & Frijters, J. (1982) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,945
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
Research works printed but not linked: 1
- Luft R, Luthman H. Mitokondriernas patofysiologi: från Lufts sjukdom till åldrande och diabetes. Lakartidningen. 1993;90:2770–5. [PubMed] [Google Scholar]
Cited by
Items 401–500 of 1,020
Insulin-sensitizing effects of omega-3 fatty acids: lost in translation?
Lalia, A., & Lanza, I. (2016) · Nutrients · doi:10.3390/nu8060329 · Cited by 141
“Although IR is more evident in obesity [8,9], it is also noted in lean individuals with a high genetic component [10–12], and has been related to a constellation of abnormalities, such as skeletal muscle mitochondrial dysfunction [13], ectopic lipid accumulation [14], liver steatosis [15], inflammation [16], oxidative…”
BackgroundYokota, T., Kinugawa, S., Hirabayashi, K., Matsushima, S., Inoue, N., Ohta, Y., Hamaguchi, S., Sobirin, M. A., Ono, T., Suga, T., et al. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00267.2009 · Cited by 141
“These findings are supported by the previous studies in patients with insulin resistance or type 2 diabetes, in which mitochondrial ATP production and state 3 respiration were decreased in skeletal muscle (23, 27).”
ResultLinks between Thyroid Hormone Action, Oxidative Metabolism, and Diabetes Risk?
Crunkhorn, S., & Patti, M.-E. (2008) · Thyroid · doi:10.1089/thy.2007.0249 · Cited by 140
Free Fatty Acids and Skeletal Muscle Insulin Resistance
Rachek, L. I. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00008-9 · Cited by 166
Abdul-Ghani, M. A., Muller, F. L., Liu, Y., Chavez, A. O., Balas, B., Zuo, P., Chang, Z., Tripathy, D., Jani, R., Molina-Carrion, M., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90287.2008 · Cited by 140
“Studies with magnetic resonance spectroscopy (MRS) have reported a mitochondrial defect in oxidative phosphorylation in insulin-resistant individuals (38), and a similar defect can be produced by elevating the plasma FFA concentration in lean, healthy, insulin-sensitive individuals (9).”
De Filippis, E., Alvarez, G., Berria, R., Cusi, K., Everman, S., Meyer, C., & Mandarino, L. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00729.2007 · Cited by 138
MicroRNAs in skin and wound healing
Banerjee, J., Chan, Y. C., & Sen, C. K. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00157.2010 · Cited by 134
Metabolic diseases and associated complications: sex and gender matter
Kautzky‐Willer, A., & Handisurya, A. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02161.x · Cited by 138
Structural and Functional Consequences of Mitochondrial Biogenesis in Human Adipocytes in Vitro
Bogacka, I., Ukropcova, B., McNeil, M., Gimble, J. M., & Smith, S. R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1024 · Cited by 138
Xu, Y. X., Nie, L., Yin, Y., Tang, J.-L., Zhou, J., Li, D., & Zhou, S.-W. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.09.028 · Cited by 144
Hey‐Mogensen, M., Højlund, K., Vind, B. F., Wang, L., Dela, F., Beck‐Nielsen, H., Fernström, M., & Sahlin, K. (2010) · Diabetologia · doi:10.1007/s00125-010-1813-x · Cited by 160
“muscle oxidative capacity), studies have either shown no differences [3–5] or a lower [6–12] mitochondrial activity in insulin-resistant participants.”
BackgroundRachek, L. I., Musiyenko, S. I., LeDoux, S. P., & Wilson, G. L. (2007) · Endocrinology · doi:10.1210/en.2006-0998 · Cited by 137
“in intramyocellular lipid content (39), reduced oxidative en-”
BackgroundHolmström, M. H., Iglesias-Gutierrez, E., Zierath, J. R., & Garcia-Roves, P. M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00159.2011 · Cited by 137
“Several lines of evidence link mitochondrial dysfunction in skeletal muscle with both the emergence of insulin resistance and the transition between normal glucose tolerance and T2DM (27, 32, 37, 38, 41).”
BackgroundPerrone, C. E., Mattocks, D. A. L., Jarvis-Morar, M., Plummer, J. D., & Orentreich, N. (2010) · Metabolism · doi:10.1016/j.metabol.2009.10.023 · Cited by 136
Mitochondrial Dysfunction in Type 2 Diabetes and Obesity
Højlund, K., Mogensen, M., Sahlin, K., & Beck-Nielsen, H. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.006 · Cited by 135
Lanza, I. R., Blachnio-Zabielska, A., Johnson, M. L., Schimke, J. M., Jakaitis, D. R., Lebrasseur, N. K., Jensen, M. D., Sreekumaran Nair, K., & Zabielski, P. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00584.2012 · Cited by 135
Exercise therapy in Type 2 diabetes
Praet, S. F. E., & van Loon, L. J. C. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0129-0 · Cited by 128
“Whether this lower oxygen uptake capacity is attributed to a low habitual physical activity level, reduced mitochondrial content or an intrinsic mitochondrial defect is a topic of intense debate [96–109].”
BackgroundDynamic MRS and MRI of skeletal muscle function and biomechanics
Prompers, J. J., Jeneson, J. A. L., Drost, M. R., Oomens, C., Strijkers, G. J., & Nicolay, K. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1095 · Cited by 151
“Shulman and coworkers have employed this technology to study mitochondrial functionality in elderly patients (73) as well as in insulin-resistant offspring of type 2 diabetic parents (74,75).”
MethodReview: Quantifying Mitochondrial Dysfunction in Complex Diseases of Aging
Horan, M. P., Pichaud, N., & Ballard, J. W. O. (2012) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glr263 · Cited by 125
Batchuluun, B., Rijjal, D. A., Prentice, K. J., Eversley, J. A., Burdett, E., Mohan, H., Bhattacharjee, A., Gunderson, E. P., Liu, Y., & Wheeler, M. B. (2018) · Diabetes · doi:10.2337/db17-1150 · Cited by 148
Rosales-Corral, S., Tan, D.-X., Manchester, L., & Reiter, R. J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/985845 · Cited by 128
Liu, J., Shen, W., Zhao, B., Wang, Y., Wertz, K., Weber, P., & Zhang, P. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.007 · Cited by 143
“Impaired mitochondrial activity also occurs in the skeletal muscle of insulin-resistant offspring of patients with type 2 diabetes [33].”
BackgroundJornayvaz, F. R., Samuel, V. T., & Shulman, G. I. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104726 · Cited by 126
Self-citationThe adipocyte–myocyte axis in insulin resistance
Sell, H., Dietze‐Schroeder, D., & Eckel, J. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.10.010 · Cited by 141
Hui, X., Zhu, W., Wang, Y., Lam, K. S. L., Zhang, J., Wu, D., Kraegen, E. W., Li, Y., & Xu, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.001107 · Cited by 130
Insulin, Aging, and the Brain: Mechanisms and Implications
Akintola, A. A., & van Heemst, D. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00013 · Cited by 124
“In support of a role of reduced efflux due to mitochondrial dysfunction, non-obese, insulin sensitive first degree relatives of patients with type 2 diabetes were shown to display impaired ability to switch to fat oxidation after high-fat intake (146), as well as higher levels of intramyocellular lipids and reduced ox…”
BackgroundMolecular mechanisms of lipid‐induced insulin resistance in muscle, liver and vasculature
Krebs, M., & Roden, M. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00439.x · Cited by 129
Metabolic dysfunction-associated steatotic liver disease and the heart
Driessen, S., Francque, S., Anker, S. D., Cabezas, M. C., Grobbee, D. E., Tushuizen, M. E., & Holleboom, A. G. (2023) · Hepatology · doi:10.1097/hep.0000000000000735 · Cited by 151
“Metabolic dysfunction – associated steatotic liver disease (MASLD) shares its root cause of insulin resistance (IR) [1] with increasing cardiometabolic health problems of obesity, [2] metabolic syndrome, [3] type 2 diabetes mellitus (T2DM), [4] hypertension, [5] and dyslipidemia.”
Troglitazone and liver injury: In search of answers†
Chojkier, M. (2005) · Hepatology · doi:10.1002/hep.20567 · Cited by 125
Role of interleukin‐6 signalling in glucose and lipid metabolism
Glund, S., & Krook, A. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01779.x · Cited by 126
“In contrast, in lean first-degree relatives of type 2 diabetic subjects, insulin resistance is evident in the absence of any elevation in IL-6 levels compared to age, fitness and weight-matched controls (Petersen et al. 2004).”
BackgroundCeramides and mitochondrial fatty acid oxidation in obesity
Fucho, R., Casals, N., Serra, D., & Herrero, L. (2016) · The FASEB Journal · doi:10.1096/fj.201601156r · Cited by 136
Diabetes, Oxidative Stress, Nitric Oxide and Mitochondria Function
Friederich, M., Hansell, P., & Palm, F. (2009) · Current Diabetes Reviews · doi:10.2174/157339909788166800 · Cited by 135
IP3Receptors, Mitochondria, and Ca2+Signaling: Implications for Aging
Decuypere, J.-P., Monaco, G., Missiaen, L., De Smedt, H., Parys, J. B., & Bultynck, G. (2011) · Journal of Aging Research · doi:10.4061/2011/920178 · Cited by 121
Coppola, G., Marmolino, D., Lu, D., Wang, Q., Cnop, M., Rai, M., Acquaviva, F., Cocozza, S., Pandolfo, M., & Geschwind, D. H. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp183 · Cited by 123
“Mitochondrial dysfunction also occurs in T2D (47), as shown by 30% reduction of ATP production in skeletal muscle, associated with increased intramyocellular lipid (IML) content and decreased aerobic/anaerobic muscle fiber ratio (40,48).”
BackgroundCentral Administration of Resveratrol Improves Diet-Induced Diabetes
Ramadori, G., Gautron, L., Fujikawa, T., Vianna, C. R., Elmquist, J. K., & Coppari, R. (2009) · Endocrinology · doi:10.1210/en.2009-0528 · Cited by 123
“Increased lipid contents negatively affect insulin sensitivity (28, 40, 41).”
BackgroundMitochondrial dynamics as a bridge between mitochondrial dysfunction and insulin resistance
Zorzano, A., Liesa, M., & Palacín, M. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450802676335 · Cited by 124
“…© 2009 Informa UK Ltd DOI: 10.1080/13813450802676335 Keywords: Mitofusin; mitochondria; mitochondrial dynamics; insulin resistance; obesity; type 2 diabetes http://www.informapharmascience.com/arp offspring from type 2 diabetic parents show reduced ATP synthesis (Petersen et al., 2003, 2004).”
BackgroundInfluentialMorino, K., Neschen, S., Bilz, S., Sono, S., Tsirigotis, D., Reznick, R. M., Moore, I., Nagai, Y., Samuel, V., Sebastian, D., et al. (2008) · Diabetes · doi:10.2337/db06-0454 · Cited by 125
Self-citationBefroy, D. E., Petersen, K. F., Dufour, S., Mason, G. F., Rothman, D. L., & Shulman, G. I. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808889105 · Cited by 120
“This is particularly relevant because a reduction in basal muscle metabolism has been associated with the development of insulin resistance in both the elderly (25) and offspring of type 2 diabetic patients (26, 27).”
BackgroundSelf-citationSchenk, S., Harber, M. P., Shrivastava, C. R., Burant, C. F., & Horowitz, J. F. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.175489 · Cited by 122
“Although previous reports indicate that insulin resistant offspring of type 2 diabetics have low oxidative capacity (Petersen et al. 2004), improved insulin action after exercise training in offspring of type 2 diabetics was found to be dissociated from an increase in oxidative capacity (Ostergard…”
BackgroundPagel-Langenickel, I., Bao, J., Joseph, J. J., Schwartz, D. R., Mantell, B. S., Xu, X., Raghavachari, N., & Sack, M. N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800842200 · Cited by 124
gp130 receptor ligands as potential therapeutic targets for obesity
Febbraio, M. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30453 · Cited by 124
Diabetes and Frailty: Two Converging Conditions?
Sinclair, A. J., & Rodríguez‐Mañas, L. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.09.004 · Cited by 133
Multi-Ethnic Study of Atherosclerosis (MESA)
Blaha, M. J., & DeFilippis, A. P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.006 · Cited by 131
Ravikumar, B., Carey, P. E., Snaar, J. E. M., Deelchand, D. K., Cook, D. B., Neely, R. D. G., English, P. T., Firbank, M. J., Morris, P. G., & Taylor, R. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00557.2004 · Cited by 123
“Defects in mitochondrial fatty acid oxidation have been reported in type 2 diabetes (13), insulinresistant offspring of type 2 diabetic subjects (25), and older normal subjects (24).”
BackgroundKarakelides, H., Asmann, Y. W., Bigelow, M. L., Short, K. R., Dhatariya, K., Coenen-Schimke, J., Kahl, J., Mukhopadhyay, D., & Nair, K. S. (2007) · Diabetes · doi:10.2337/db07-0378 · Cited by 123
Yasuda, M., Tanaka, Y., Kume, S., Morita, Y., Chin-Kanasaki, M., Araki, H., Isshiki, K., Araki, S.-I., Koya, D., Haneda, M., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.001 · Cited by 123
“Insufficiency of insulin action to skeletal muscle and the liver leads to hyperglycemia [3,4], which strongly associates with both the onset and progression of diabetic vascular complications [5–8].”
Rovira‐Llopis, S., Apostolova, N., Bañuls, C., Muntané, J., Rocha, M., & Víctor, V. M. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7313 · Cited by 133
“…of PKCs. Studies in humans have highlighted the association of insulin resistance with several mitochondrial abnormalities, such as changes in mitochondrial morphology, reduced number of mitochondria, presence of mitochondrial dysfunction, or reduction in mitochondrial oxidative enzymes (139, 239).”
Exercise, heat shock proteins and insulin resistance
Archer, A. E., Von Schulze, A. T., & Geiger, P. C. (2018) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0529 · Cited by 122
Enhanced Skeletal Muscle for Effective Glucose Homeostasis
Yang, J. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00005-3 · Cited by 149
FRIDLYAND, L. E., & PHILIPSON, L. H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1363.019 · Cited by 126
TNF-α induces mitochondrial dysfunction in 3T3-L1 adipocytes
Chen, X.-H., Zhao, Y., Xue, M., Ji, C., Gao, C., Zhu, J., Qin, D., Kou, C., Qin, X., Tong, M., et al. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.07.005 · Cited by 137
Clinical Implications of Mitochondrial Dysfunction
Muravchick, S., Levy, R. J., & Warltier, D. C. (2006) · Anesthesiology · doi:10.1097/00000542-200610000-00029 · Cited by 122
Mitochondrial Biogenesis in Health and Disease. Molecular and Therapeutic Approaches
Sanchis-Gomar, F., Garcia-Gimenez, J., Gomez-Cabrera, M., & Pallardo, F. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140306095106 · Cited by 118
“[155, 156].”
Wang, C., Wang, C., & Wei, Y. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05625.x · Cited by 119
Victor, V. M., Rocha, M., Bañuls, C., Sanchez-Serrano, M., Sola, E., Gomez, M., & Hernandez-Mijares, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0466 · Cited by 115
Houten, S. M., & Auwerx, J. H. (2004) · Cell · doi:10.1016/j.cell.2004.09.016 · Cited by 134
“…resistance and predisposition1 is expressed in heart, kidney, brown adipose tissue (BAT), and brain and was originally described as a to diabetes (Petersen et al., 2004 and references therein), PGC-1 / mice are lean and resistant to diet-cold-inducible coactivator controlling adaptive…”
BackgroundWilkins, H. M., Harris, J. L., Carl, S. M., E, L., Lu, J., Eva Selfridge, J., Roy, N., Hutfles, L., Koppel, S., Morris, J., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu371 · Cited by 118
“In at least some tissues impaired mitochondrial function causes insulin resistance (48).”
BackgroundMitchell, C. S., Savage, D. B., Dufour, S., Schoenmakers, N., Murgatroyd, P., Befroy, D., Halsall, D., Northcott, S., Raymond-Barker, P., Curran, S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38793 · Cited by 116
Self-citationBoesch, C. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20806 · Cited by 131
“A combination of (31)P-MRS to assess the rates of mitochondrial oxidative-phosphorylation activity in muscle and (1)H-MRS to measure IMCL and intrahepatic triglyceride content was used to investigate impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes (51).”
MethodThe role of mitochondria in the aetiology of insulin resistance and type 2 diabetes
Martin, S. D., & McGee, S. L. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.09.019 · Cited by 113
Avila, C., Huang, R., Stevens, M., Aponte, A. M., Tripodi, D., Kim, K., & Sack, M. N. (2011) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0031-1285833 · Cited by 124
“The attenuation of mitochondrial oxygen consumption in insulin responsive tissues and in the pancreas during diabetes is well established and this is often associated with the downregulation of oxidative phosphorylation proteins [11].”
BackgroundDe Feyter, H. M., van den Broek, N. M. A., Praet, S. F. E., Nicolay, K., van Loon, L. J. C., & Prompers, J. J. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0756 · Cited by 116
“As an alternative to measuring muscle oxidative capacity from dynamic 31P MRS experiments after exercise, Petersen et al. applied 31P MRS saturation transfer experiments to measure mitochondrial ATP synthesis rates in resting skeletal muscle of healthy, young, lean, insulin-resistant offspring of type 2 diabetes patie…”
Eringa, E. C., Bakker, W., Smulders, Y. M., Serné, E. H., Yudkin, J. S., & Stehouwer, C. D. A. (2007) · Microcirculation · doi:10.1080/10739680701303584 · Cited by 125
“Obesity-related insulin resistance of muscle is associated with impairment of insulin-mediated nutritive blood flow [42], reduction of endothelium-dependent vasodilatation and NO synthesis [149–151], ectopic disposition of lipids [96] and infiltration of macrophages [90].”
BackgroundTaddeo, E. P., Laker, R. C., Breen, D. S., Akhtar, Y. N., Kenwood, B. M., Liao, J. A., Zhang, M., Fazakerley, D. J., Tomsig, J. L., Harris, T. E., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.11.003 · Cited by 120
“Furthermore, skeletal muscle of young insulin resistant pre-diabetic patients that are non-obese also demonstrates mitochondrial dysfunction and aberrant lipid accumulation [11].”
Backgroundvan der Veen, J. N., Lingrell, S., da Silva, R. P., Jacobs, R. L., & Vance, D. E. (2014) · Diabetes · doi:10.2337/db13-0993 · Cited by 114
“Muscle mitochondrial activity is reduced in diabetic patients (32; 35) as well as in IR children of type 2 diabetic patients (34).”
Vodovotz, Y., Barnard, N. D., Hu, F. B., Jakicic, J. M., Lianov, L. S., Loveland, D., Buysse, D. J., Szigethy, E., Finkel, T., Sowa, G., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.585744 · Cited by 139
“Studies should also focus on our current understanding of diet quality (52, 67) considering the quality of fats, carbohydrates, and protein not merely their relative proportions.”
BackgroundImpact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
Wang, L., Cai, Y., Jian, L., Cheung, C. W., Zhang, L., & Xia, Z. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01188-0 · Cited by 120
“In diabetic hearts, however, increased fatty acid uptake and decreased glucose utilization have been observed in animal models and patients [19, 20].”
BackgroundRasouli, N., Yao‐Borengasser, A., Miles, L. M., Elbein, S. C., & Kern, P. A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00240.2005 · Cited by 122
“Impaired muscle lipid oxidative capacity has been noted to be an early feature of insulin resistance (23).”
Shah, S., Iqbal, M., Karam, J., Salifu, M., & McFarlane, S. I. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1629 · Cited by 115
“Human studies using 13 C and 31 P magnetic resonance spectroscopy in offsprings of parents with type 2 diabetes have suggested mitochondrial dysfunction as a possible contributing factor to the development of diabetes (222).”
Cariou, B., Langhi, C., Le Bras, M., Bortolotti, M., Lê, K.-A., Theytaz, F., Le May, C., Guyomarc’h-Delasalle, B., Zaïr, Y., Kreis, R., et al. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-4 · Cited by 110
“5 g/kg/day) diet (HFruc1) was performed in healthy male volunteers and in healthy OffT2D subjects [24], who are more prone to develop insulin resistance [29-31].”
BackgroundObesity as the Main Risk Factor for Metabolic Syndrome in Children
Gepstein, V., & Weiss, R. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00568 · Cited by 104
“These include a genetic background such as that observed in lean and healthy young adult offspring of patients with T2DM (19).”
BackgroundYan, J., Feng, Z., Liu, J., Shen, W., Wang, Y., Wertz, K., Weber, P., Long, J., & Liu, J. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.03.014 · Cited by 118
“dysfunction may give rise to IR [7,8], mitochondrial dysfunction resulting from oxidative stress induced by a high-fat diet appears to be a successor of IR [10].”
BackgroundMitochondrial sirtuins: Emerging roles in metabolic regulations, energy homeostasis and diseases
Parihar, P., Solanki, I., Mansuri, M. L., & Parihar, M. S. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.12.004 · Cited by 117
“…related to the physical inactivity, high calorie diet, increased inflammation, reduced fatty acid oxidation, increased oxidative stress, and aging (Petersen et al., 2004; Uysal et al., 1997; Ji and Friedman, 2007) and any effort to regulate these events might be helpful in preventing metabolic…”
BackgroundAltered lipid metabolism in a Drosophila model of Friedreich's ataxia
Navarro, J. A., Ohmann, E., Sánchez, D., Botella, J., Liebisch, G., Moltó, M. D., Ganfornina, M. D., Schmitz, G., & Schneuwly, S. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq183 · Cited by 124
“Moreover, up to 40% of FRDA patients manifest different glucose metabolism problems (53) such as diabetes or insulin resistance, and remarkably type 2 diabetes patients also present an altered lipid status attributable to a mitochondrial dysfunction (54,55).”
BackgroundFatty liver and the metabolic syndrome
Neuschwander-Tetri, B. A. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32801421a9 · Cited by 113
Ruggenenti, P. L., Cattaneo, D., Loriga, G., Ledda, F., Motterlini, N., Gherardi, G., Orisio, S., & Remuzzi, G. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.132522 · Cited by 126
Non-alcoholic fatty liver disease and insulin resistance: From bench to bedside
Gariani, K., Philippe, J., & Jornayvaz, F. R. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.11.002 · Cited by 113
“[90] Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI.”
BackgroundErythropoietin: Elucidating new cellular targets that broaden therapeutic strategies
Maiese, K., Chong, Z. Z., Li, F., & Shang, Y. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.02.002 · Cited by 119
Ma, H., Jiang, T., Tang, W., Ma, Z., Pu, K., Xu, F., Chang, H., Zhao, G., Gao, W., Li, Y., et al. (2020) · Clinical Science · doi:10.1042/cs20200530 · Cited by 119
Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes
Roszczyc-Owsiejczuk, K., & Zabielski, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.635175 · Cited by 123
AMPK-mediated regulation of transcription in skeletal muscle
McGee, S. L., & Hargreaves, M. (2010) · Clinical Science · doi:10.1042/cs20090533 · Cited by 112
Fritz, T., Krämer, D. K., Karlsson, H. K. R., Galuska, D., Engfeldt, P., Zierath, J. R., & Krook, A. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.656 · Cited by 114
“Clinical studies show that mitochondrial dysfunction plays a role in the development of insulin resistance in the elderly [22] and insulin-resistant offspring of type 2 diabetic patients [23].”
BackgroundAguer, C., Mercier, J. G., Man, C. Y. W., Metz, L., Bordenave, S., Lambert, K., Jean, E., Lantier, L., Bounoua, L., Brun, J. ‐., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1708-x · Cited by 118
“Several studies have provided evidence of mitochondrial dysfunction in skeletal muscle of type 2 diabetic and prediabetic participants [1, 8, 9, 11, 12].”
BackgroundRole of oxidative stress in diabetic nephropathy
Vasavada, N., & Agarwal, R. (2005) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2005.01.001 · Cited by 126
Konopka, A. R., Asante, A., Lanza, I. R., Robinson, M. M., Johnson, M. L., Dalla Man, C., Cobelli, C., Amols, M. H., Irving, B. A., & Nair, K. S. (2015) · Diabetes · doi:10.2337/db14-1701 · Cited by 112
Insulin resistance in patients with rheumatoid arthritis: effect of anti‐TNFα therapy
Rosenvinge, A., Krogh‐Madsen, R., Baslund, B., & Pedersen, B. K. (2007) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740601179605 · Cited by 112
“In humans, circulating IL-6 levels may (37, 38) or may not (39, 40) be associated with insulin resistance.”
BackgroundHenstridge, D. C., Whitham, M., & Febbraio, M. A. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.08.003 · Cited by 111
“Skeletal muscle of insulin-resistant offspring of patients with T2DM is associated with dysregulated fatty acid metabolism, possibly due to an inherited defect in mitochondrial oxidative phosphorylation [65].”
BackgroundMitochondrial oxidative function and type 2 diabetes
Rabøl, R., Boushel, R., & Dela, F. (2006) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h06-071 · Cited by 112
“The reduction in mitochondrial density of the young and lean IR offspring is comparable with the 30% reduction in ATP production previously reported (Petersen et al. 2004).”
BackgroundMethodImpaired estrogen receptor action in the pathogenesis of the metabolic syndrome
Hevener, A. L., Clegg, D. J., & Mauvais-Jarvis, F. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.05.020 · Cited by 112
“Although reductions in mitochondrial number and function have been implicated in the pathobiology of insulin resistance (Befroy et al., 2007; Morino et al., 2005; Patti et al., 2003; Petersen et al., 2004), and indeed gender dimorphisms in mitochondrial biology have been described (Gomez-Perez et al.”
Backgroundvan Tienen, F. H. J., Praet, S. F. E., de Feyter, H. M., van den Broek, N. M., Lindsey, P. J., Schoonderwoerd, K. G. C., de Coo, I. F. M., Nicolay, K., Prompers, J. J., Smeets, H. J. M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3454 · Cited by 111
“Furthermore, the observed reduction in basal ATP production in insulin-resistant offspring of T2DM patients (27) may also be the result of impaired insulin signaling affecting insulin-dependent mitochondrial process (28, 29), which is also observed in studies analyzing the effect of insulin infusion on mitochondrial A…”
Distinct populations of adipogenic and myogenic Myf5-lineage progenitors in white adipose tissues
Shan, T., Liang, X., Bi, P., Zhang, P., Liu, W., & Kuang, S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m038711 · Cited by 129
Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration?
Scheele, C., Nielsen, A. R., Walden, T. B., Sewell, D. A., Fischer, C. P., Brogan, R. J., Petrovic, N., Larsson, O., Tesch, P. A., Wennmalm, K., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8520com · Cited by 110
Ageing, adipose tissue, fatty acids and inflammation
Pararasa, C., Bailey, C. J., & Griffiths, H. R. (2015) · Biogerontology · doi:10.1007/s10522-014-9536-x · Cited by 110
“This is especially important in insulin-resistant states (Kelley and Mandarino 2000; Petersen et al. 2004) and in older adults (Petersen et al.”
Molero, J. C., Jensen, T. E., Withers, P. C., Couzens, M., Herzog, H., Thien, C. B. F., Langdon, W. Y., Walder, K., Murphy, M. A., Bowtell, D. D. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21480 · Cited by 107
“This, together with other recent work in this area (12, 13), points to muscle mitochondrial function as a key therapeutic target for the treatment of type 2 diabetes and obesity.”
BackgroundHypophosphatemia promotes lower rates of muscle ATP synthesis
Pesta, D. H., Tsirigotis, D. N., Befroy, D. E., Caballero, D., Jurczak, M. J., Rahimi, Y., Cline, G. W., Dufour, S., Birkenfeld, A. L., Rothman, D. L., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600473r · Cited by 117
Self-citationA mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians
Park, K. S., Chan, J. C. N., Chuang, L., Suzuki, S., Araki, E., Nanjo, K., Liang, J., Ng, M. C. Y., Nishi, M., Furuta, H., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-0933-z · Cited by 118
“Mitochondrial dysfunction plays a critical role in the pathogenesis of insulin resistance and diabetes mellitus [1].”
BackgroundMechanisms for abnormal postprandial glucose metabolism in type 2 diabetes
Woerle, H. J., Szoke, E., Meyer, C., Dostou, J. M., Wittlin, S. D., Gosmanov, N. R., Welle, S. L., & Gerich, J. E. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00529.2004 · Cited by 109
“This intracellular defect, which persisted despite the apparent ability of hyperglycemia to overcome defects in glucose transport, is consistent with and provides additional support for the concept that impaired mitochondrial activity might represent a fundamental defect in T2DM (52, 53).”
ResultHartman, M.-L., Shirihai, O. S., HOLBROOK, M. M., Xu, G., Kocherla, M., Shah, A. K., Fetterman, J. L., Kluge, M. A., Frame, A. A., Hamburg, N. M., et al. (2014) · Vascular Medicine · doi:10.1177/1358863x14521315 · Cited by 125
Schenk, S., & Horowitz, J. F. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00051.2006 · Cited by 108
“In addition, low rates of skeletal muscle fatty acid oxidation, in association with reduced mitochondrial number and/or function, have also been linked with insulin resistance in obesity (20, 24, 28).”
Chen, X., Wang, L., Wu, Y.-Z., Song, S.-Y., Min, H.-Y., Yang, Y., He, X., Liang, Q., Yi, L., Wang, Y., et al. (2018) · Nutrition and Diabetes · doi:10.1038/s41387-017-0009-6 · Cited by 112
Metadata
- Authors
- Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I.
- Affiliations
- Yale University (US)
- Howard Hughes Medical Institute (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-02-12
- Volume
- 350
- Issue
- 7
- Pages
- 664-671
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2995502
- OpenAlex
- W2027670788
- Cited by
- 2,193
- References
- 44
- Citations by year
- 2026: 38 · 2025: 38 · 2024: 51 · 2023: 71 · 2022: 47 · 2021: 75 · 2020: 87 · 2019: 59 · 2018: 84 · 2017: 87 · 2016: 87 · 2015: 88 · 2014: 97 · 2013: 113 · 2012: 122
- FWCI
- 101.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01-AG-23686, R01AG023686)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK063192, P30DK45735, R01DK049230, R01 DK-49230, K-23 DK-02347, P30DK045735)
- National Center for Research Resources (M01RR000125, M01 RR-00125)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- insulin resistance, type 2 diabetes, offspring of diabetic patients, mitochondrial dysfunction, oxidative phosphorylation, skeletal muscle glucose uptake, intramyocellular lipid, fatty acid metabolism, hepatic insulin sensitivity, glycerol turnover, 31P NMR, 1H NMR, hyperinsulinemic-euglycemic clamp
- MeSH terms
- Adenosine Triphosphate, Adipose Tissue, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Female, Glucose, Glucose Tolerance Test, Glycerol, Humans, Insulin, Insulin Resistance, Lipolysis, Male, Mitochondria, Magnetic Resonance Spectroscopy, Oxidative Phosphorylation, Triglycerides, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.